High expression of HIF-2α and its anti-radiotherapy effect in lung cancer stem cells

Hypoxia-inducible factor-2 alpha (HIF-2 alpha) has been shown to regulate cell stemness, although the expression and effects of HIF-2 alpha in lung cancer stem cells remained unclear. This study investigated HIF-2 alpha expression in lung cancer stem cells, as well as the relationship between HIF-2 alpha expression and radioresistance in lung cancer cells. Stem-like cells (CD133(+)) in the non-small-cell lung cancer cell line A549 were enriched by serum-free culture conditions, and CD133(+) cells were sorted via fluorescence-activated cell sorting. A549 cells were treated with middle-infrared radiation, and the level of HIF-2 alpha expression was determined by a quantitative polymerase chain reaction assay and western blot analysis. The level of HIF-2 alpha expression in tissue sections from 50 cases of clinically confirmed non-small-cell lung cancer was determined via immunohistochemical analysis, and its correlation with prognosis after radiotherapy was analyzed. HIF-2 alpha levels in CD133(+) cells were significantly higher than those in CD133(-) cells (P = 0.032). However, after radiation treatment, these levels were significantly upregulated in both CD133(+) and CD133(-) cells (P = 0.031 and P = 0.023, respectively). After irradiation, the proportions of apoptotic, dead, and autophagic CD133(+) A549 cells considerably lower than those of CD133-A549 cells (P < 0.05). Furthermore, the recovery of carcinoembryonic antigen to pre-radiation levels was more rapid in lung cancer patients with high levels of HIF-2 alpha expression, and these patients had shorter survival times (P = 0.018). HIF-2 alpha is highly expressed in lung cancer stem cells, which may lead to radioresistance. In conclusion, HIF-2 alpha is a potential prognostic marker for lung cancer.were